After the FDA approved Zepbound for moderate-to-severe OSA in December 2024, most Cigna plans added an OSA coverage pathway
Grounded in peer-reviewed science and global clinical trials
They will assess your medical history and weight loss goals, then prescribe a compounded GLP-1 medication if appropriate, which will be prepared and delivered by a regulated compounding pharmacy
Beyond tirzepatide and retatrutide, Eli Lilly is also investing in oral GLP-1 therapies ( orforglipron ), aiming to provide convenient, effective alternatives to injections
Research has shown that IGF1 LR3 enhances glucose uptake in muscle and adipose tissue through mechanisms similar to insulin, including GLUT4 translocation to the cell membrane
"As someone with a busy lifestyle, this spray fits perfectly